Covered recipient · General Payments record
BRETA D BOOTS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$6,208.35
- Reported across 356 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $353.30 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $117.13 | 6 |
| EISAI INC. | $89.65 | 4 |
| Lilly USA, LLC | $63.10 | 3 |
| Otsuka America Pharmaceutical, Inc. | $47.77 | 2 |
| PFIZER INC. | $18.51 | 1 |
| Axsome Therapeutics, Inc. | $17.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.78 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540660 | CMS |
| ABBVIE INC. | $15.75 | 03/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540662 | CMS |
| ABBVIE INC. | $15.00 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540664 | CMS |
| ABBVIE INC. | $25.19 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540666 | CMS |
| ABBVIE INC. | $18.20 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540668 | CMS |
| ABBVIE INC. | $20.21 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201540670 | CMS |
| Axsome Therapeutics, Inc. | $17.14 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235441891 | CMS |
| Eisai Inc. | $23.42 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244468139 | CMS |
| Eisai Inc. | $24.98 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244468146 | CMS |
| Eisai Inc. | $23.42 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244468143 | CMS |
| Eisai Inc. | $17.83 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244468150 | CMS |
| Lilly USA, LLC | $22.16 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186472019 | CMS |
| Lilly USA, LLC | $20.38 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186529107 | CMS |
| Lilly USA, LLC | $20.56 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186480725 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.43 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227298002 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.34 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227298004 | CMS |
| PFIZER INC. | $18.51 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229235134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.